Arrhythmogenic Right Ventricular Dysplasia Treatment Market Growth During the Forecast Period, 2018-2026
By epidemiology, according to the Centers for Diseases Control and Prevention, arrhythmogenic right ventricular dysplasia has a prevalence of 1 in 2500 to 1 in 5000 population. The increase in the prevalence of the disease is expected to drive the growth of the Arrhythmogenic Right Ventricular Dysplasia Treatment Market. Increasing prevalence of congenital heart diseases is also a major factor due to which cardiomyopathy diagnostic is high in demand in the recent years. Many manufacturers are focusing on research and...
View full press release